Iran's armed forces have targeted U.S. military infrastructure in Kuwait, Qatar, and Bahrain, escalating a conflict that has shattered a three-week-old ceasefire. The retaliatory strikes followed U.S. attacks on Iranian coastal provinces, raising fresh concerns over the stability of global energy supply routes.
Iraq's prime minister has confirmed the country will remain in OPEC, quelling exit speculation, but will pursue a 'fair' increase in its oil production allowance within the group.
The U.S. stock market rally, driven by a 21% surge in forward earnings estimates, is entering a critical phase as Q2 results will determine if companies can meet these heightened expectations.
Ionis Pharmaceuticals (NASDAQ:IONS) stock fell over 20% after its cardiovascular drug eplontersen, developed with AstraZeneca, failed to meet its primary goals in a large-scale Phase 3 study. The setback significantly alters the drug's commercial outlook and benefits competitor Alnylam.
Porsche AG stock fell after the luxury automaker reported a 16% drop in global vehicle deliveries for the first half of 2026, citing significant weakness in China and North America.
The Finnish insurer's stock gained after Goldman Sachs raised its rating to 'Buy' and lifted its price target, pointing to an improving pricing cycle and projecting strong earnings growth.
The Danish shipping giant announced the restoration of its trans-Suez route for its Middle East to U.S. East Coast service, a move expected to significantly reduce transit times and improve supply chain efficiency.
Analysts at UBS maintain a bearish outlook on the EUR/NOK currency pair, forecasting a steady appreciation of the Norwegian krone through mid-2027 despite its recent pullback.
The rapid expansion of artificial intelligence is straining the supply of critical grid components like transformers, forcing U.S. power companies to contend with multi-year delays and rising costs for essential equipment.
